CDK2

Alternative Name: Cyclin-dependent kinases (CDKs)

Target

Product Details

User: Male

Hormonal: Yes

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: University of Kansas Medical Center, University of Minnesota, Moffitt Cancer Center at University of South Florida

Project Phase: Discovery and Early Development

Development Stage: Target Identification

Active Development: Yes

Additional Information

References:

Vertical Tabs

Print